<DOC>
	<DOCNO>NCT00388245</DOCNO>
	<brief_summary>REHEAT 2 study design prospective , randomised trial compare two strategy myocardial revascularisation ( PCI v CABG ) patient ischemic cardiomyopathy low leave ventricular ejection fraction.Patients undergo random way PCI CABG procedure . The aim study ass improvement leave ventricle systolic function compare recent ( 30 day ) late ( 12 month ) result surgical ( CABG ) percutaneous ( PCI ) revascularization .</brief_summary>
	<brief_title>Revascularization Heart Failure Trial – REHEAT 2</brief_title>
	<detailed_description>Heart failure constitute one basic problem contemporary cardiology . It commonly cause ischaemic heart disease , etiologic factor , negative impact prognosis . On hand , decrease leave ventricular ejection fraction important prognostic factor patient ischaemic heart disease . Annual mortality among patient ejection fraction 35 % account 17 % , group ejection fraction 25 % reach 24 % . Most multicenter study ( e.g . ARTS , BARI , ERACI ) compare result percutaneous surgical revascularisation ischemic heart disease pertain patient normal minimally decrease leave ventricular ejection fraction , exclude patient leave ventricular ejection fraction lower 35 % . Current medical standard indicate surgical way method choice treatment patient ischemic cardiomyopathy . In early ninety procedures percutaneous angioplasty patient depressed leave ventricular function connect comparable CABG risk death ( 5-10 % ) . The intensive progress percutaneous procedure contribute PCI competitive method revasularization CABG . Our knowledge efficacy mention method patient ischemic heart failure scarce . It prove , patient viable myocardium assess dobutamine stress echocardiography MRI benefit mostly myocardial revascularization . Repeat revascularization follow occur frequently patient PCI , introduction coronary stent , especially drug elute stent ( DES ) could significantly improve clinical outcome PCI procedure . The administration antiplatelet drug ( IIb/IIIa platelet receptor inhibitor ) considerably improve short long-term result PCI interesting could beneficial effect clinical outcome patient ischemic heart failure . In field cardiac surgery method leave ventricle reconstruction patient ischemic cardiomyopathy ( STICH Trial ) seem promise . Therefore , comparison innovative method percutaneous surgical revascularization may influence current medical standard concern patient ischemic heart disease .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>symptomatic coronary artery disease ( angina CCS class 1 ) leave ventricle ejection fraction &lt; 40 % coronary artery lesion suitable percutaneous surgical myocardial revascularisation evidence viability myocardium write inform consent study age &lt; 18 year acute myocardial infarct ST elevation within 30 day concomitant congenital heart disease mitral regurgitation require surgical intervention history bleed diathesis , coagulopathy abnormal bleeding within previous 30 day . major surgery within previous 6 week stroke transient ischemic attack ( TIA ) within previous 6 week history hemorrhagic stroke uncontrolled hypertension chronic renal insufficiency creatinine &gt; 2.0 mg/dl platelet count &lt; 100.000/mm3 hematocrit &lt; 30 % PT &gt; 1,2 time control positive pregnancy test disease may shorten life expectancy patient patient currently participate another research study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>PCI</keyword>
	<keyword>CABG</keyword>
	<keyword>Ejection Fraction</keyword>
	<keyword>Myocardial Revascularization</keyword>
</DOC>